Skip to content
OpenCapital
Get started

CNS Pharmaceuticals CNSP Q4 2025 Annual earnings

Reported March 31, 2026 · After market close

Diluted EPS-$5.09In line
EPS estimate-$5.09

Next report

Aug 17, 2026 (in a month)
EPS estimate-$0.24

Versus estimates

Diluted EPS

Q1 2026-$7.30Miss by $1.93
Q4 2025-$5.09In line
Q3 2025-$5.76Beat by $0.87Q2 2025-$6.42Beat by $3.18Q3 2024-$150.06Miss by $149.96Q2 2024-$4,033.61Miss by $448.18

Ask the moment CNS Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did CNS Pharmaceuticals report Q4 2025 earnings?
CNS Pharmaceuticals (CNSP) reported Q4 2025 earnings on March 31, 2026 after market close.
What were CNS Pharmaceuticals's Q4 2025 revenue and EPS?
CNS Pharmaceuticals reported diluted EPS of $-5.09 for Q4 2025.
Did CNS Pharmaceuticals beat estimates in Q4 2025?
EPS beat the consensus estimate of $-5.09 by $0.00.
Where can I find CNS Pharmaceuticals's Q4 2025 SEC filings?
You can read the 10-K periodic report (0001683168-26-002550) directly on SEC EDGAR. The filing index links above go to sec.gov.